BRIEF-BioVersys Launches IPO On Six Swiss Exchange And Sets IPO Price At CHF 36 Per Share

Reuters

01-29

BRIEF-BioVersys Launches IPO On Six Swiss Exchange And Sets IPO Price At CHF 36 Per Share

Jan 29 (Reuters) - BIOVERSYS:

LAUNCHES IPO ON SIX SWISS EXCHANGE AND SETS IPO PRICE AT CHF 36.00 PER SHARE
PRICE FOR OFFERED SHARES HAS BEEN SET AT CHF 36.00 PER SHARE
LISTING AND FIRST DAY OF TRADING ON SIX SWISS EXCHANGE ARE EXPECTED TO TAKE PLACE ON FEBRUARY 07, 2025
EXPECTED TO BE INCLUDED IN SWISS PERFORMANCE INDEX $(SPI)$ ON ITS SECOND TRADING DAY, FEBRUARY 10, 2025
OFFER PERIOD STARTS JANUARY 29 AND IS SEEN TO END ON FEBRUARY 05, 2025

Source text: ID:nEQ3b1kxga

Further company coverage: [ ]

(Gdansk Newsroom)

((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2507060885"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2507060885\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2507060885?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-29 14:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2507060885","market":"us","top_or_hot":-1,"title":"BRIEF-BioVersys Launches IPO On Six Swiss Exchange And Sets IPO Price At CHF 36 Per Share","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-BioVersys Launches IPO On Six Swiss Exchange And Sets IPO Price At CHF 36 Per Share</title></head><body><p><span>Jan 29 (Reuters)</span><span> - </span>BIOVERSYS:</p><ul><li><p>LAUNCHES IPO ON SIX SWISS EXCHANGE AND SETS IPO PRICE AT CHF 36.00 PER SHARE</p></li><li><p>PRICE FOR OFFERED SHARES HAS BEEN SET AT CHF 36.00 PER SHARE</p></li><li><p>LISTING AND FIRST DAY OF TRADING ON SIX SWISS EXCHANGE ARE EXPECTED TO TAKE PLACE ON FEBRUARY 07, 2025</p></li><li><p>EXPECTED TO BE INCLUDED IN SWISS PERFORMANCE INDEX <a href=\"https://laohu8.com/S/SPI\">$(SPI)$</a> ON ITS SECOND TRADING DAY, FEBRUARY 10, 2025</p></li><li><p>OFFER PERIOD STARTS JANUARY 29 AND IS SEEN TO END ON FEBRUARY 05, 2025</p></li></ul><p>Source text: <span>ID:nEQ3b1kxga</span></p><p>Further company coverage: [ ]</p><p> (Gdansk Newsroom)</p><p> ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-BioVersys Launches IPO On Six Swiss Exchange And Sets IPO Price At CHF 36 Per Share</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-BioVersys Launches IPO On Six Swiss Exchange And Sets IPO Price At CHF 36 Per Share\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-01-29 14:06</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-BioVersys Launches IPO On Six Swiss Exchange And Sets IPO Price At CHF 36 Per Share</title></head><body><p><span>Jan 29 (Reuters)</span><span> - </span>BIOVERSYS:</p><ul><li><p>LAUNCHES IPO ON SIX SWISS EXCHANGE AND SETS IPO PRICE AT CHF 36.00 PER SHARE</p></li><li><p>PRICE FOR OFFERED SHARES HAS BEEN SET AT CHF 36.00 PER SHARE</p></li><li><p>LISTING AND FIRST DAY OF TRADING ON SIX SWISS EXCHANGE ARE EXPECTED TO TAKE PLACE ON FEBRUARY 07, 2025</p></li><li><p>EXPECTED TO BE INCLUDED IN SWISS PERFORMANCE INDEX <a href=\"https://laohu8.com/S/SPI\">$(SPI)$</a> ON ITS SECOND TRADING DAY, FEBRUARY 10, 2025</p></li><li><p>OFFER PERIOD STARTS JANUARY 29 AND IS SEEN TO END ON FEBRUARY 05, 2025</p></li></ul><p>Source text: <span>ID:nEQ3b1kxga</span></p><p>Further company coverage: [ ]</p><p> (Gdansk Newsroom)</p><p> ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0289739699.SGD","symbol_name":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250129:nFWN3OO1T6:1","article_id":"2507060885","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2507060885","pubTimestamp":1738130819,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-BioVersys Launches IPO On Six Swiss Exchange And Sets IPO Price At CHF 36 Per ShareJan 29 (Reuters) - BIOVERSYS:LAUNCHES IPO ON SIX SWISS EXCHANGE AND SETS IPO PRICE AT CHF 36.00 PER SHAREPRICE ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU0971552830.HKD":"ALLIANZ EUROPEAN EQUITY DIVIDEND \"AM\" (HKDHDG) INC","LU0545562505.USD":"NINETY ONE GSF GLOBAL QUALITY DIVIDEND GROWTH \"A\" (USD) INC","LU0203345920.USD":"SCHRODER ISF QEP GLB ACT. VL \"A\" (USD) ACC","BK5011":"制药","LU1481599808.USD":"THREADNEEDLE (LUX) UK EQUITY INCOME \"AUC\" (USDHDG) INC","LU1015430645.USD":"SCHRODER ISF UK EQUITY \"A\" (USDHDG) ACC","LU1645745479.HKD":"ALLIANZ EUROPE INCOME AND GROWTH \"AM\" (HKDHDG) INC","LU0306806265.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" ACC","LU0971552673.USD":"Allianz European Equity Dividend Cl AM DIS H2-USD","LU0225771236.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (USD) INC MF","LU1035777561.USD":"AB SICAV I - EUROPEAN EQUITY PORTFOLIO \"A\" (USDHDG) ACC","LU1400636491.USD":"Allianz Europe Income and Growth Cl AMg DIS H2-USD","LU1400636657.SGD":"Allianz Europe Income and Growth Cl AMg DIS H2-SGD","LU1098665638.USD":"FRANKLIN MUTUAL EUROPEAN \"A\" (USDHDG) H1 ACC","LU1481600234.SGD":"THREADNEEDLE (LUX) UK EQUITY INCOME \"ASC\" (SGDHDG) INC","IE00BQJZX424.USD":"FRANKLIN MV EUROPEAN EQUITY GROWTH AND INCOME \"A\" (USDHDG) INC","LU1228905037.USD":"NINETY ONE GSF GLOBAL QUALITY DIVIDEND GROWTH \"A\" (USD) ACC","LU1046248800.SGD":"Allianz European Equity Dividend Cl AM DIS H2-SGD","IE00BWDBJ516.SGD":"Legg Mason QS - MV European Equity Growth and Income A Mdis SGD-H Plus","LU0306807586.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" (USD) INC QF","LU0575583348.USD":"SCHRODER ISF UK EQUITY \"A\" (USD) INC AV","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","LU1202635105.USD":"ALLIANZ EUROPE INCOME AND GROWTH \"AM\" (USDHDG) INC","LU1487256676.USD":"THREADNEEDLE (LUX) UK EQUITY INCOME \"ZUH\" (USDHDG) ACC","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","LU1228905540.USD":"NINETY ONE GSF GLOBAL QUALITY DIVIDEND GROWTH \"A\" (USD) INC 2","LU1064927863.SGD":"JPMorgan Funds - Europe Dynamic A (acc) SGD-H","LU0985481810.HKD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (HKD) INC M","LU0225284248.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" ACC","LU0058720904.USD":"联博国际健康护理基金A","LU1670756490.USD":"ALLIANZ EUROPE INCOME AND GROWTH \"AT\" (USDHDG) ACC","LU0109981661.USD":"FRANKLIN MUTUAL EUROPEAN \"A\" (USD) ACC","LU1302929846.USD":"ALLIANZ EUROPEAN EQUITY DIVIDEND \"AMG\" (USDHDG) INC","LU1400636574.HKD":"ALLIANZ EUROPE INCOME AND GROWTH \"AMG\" (HKDHDG) INC","GSK.UK":"葛兰素史克","IE0034235071.USD":"PINEBRIDGE EUROPE RESEARCH ENHANCED EQUITY \"A\" (USD) ACC"},"translate_title":"简介-BioVersys在瑞士六家交易所启动IPO，IPO价格定为每股36瑞士法郎","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GSK.UK":0.9},"content_text":"BRIEF-BioVersys Launches IPO On Six Swiss Exchange And Sets IPO Price At CHF 36 Per ShareJan 29 (Reuters) - BIOVERSYS:LAUNCHES IPO ON SIX SWISS EXCHANGE AND SETS IPO PRICE AT CHF 36.00 PER SHAREPRICE FOR OFFERED SHARES HAS BEEN SET AT CHF 36.00 PER SHARELISTING AND FIRST DAY OF TRADING ON SIX SWISS EXCHANGE ARE EXPECTED TO TAKE PLACE ON FEBRUARY 07, 2025EXPECTED TO BE INCLUDED IN SWISS PERFORMANCE INDEX $(SPI)$ ON ITS SECOND TRADING DAY, FEBRUARY 10, 2025OFFER PERIOD STARTS JANUARY 29 AND IS SEEN TO END ON FEBRUARY 05, 2025Source text: ID:nEQ3b1kxgaFurther company coverage: [ ] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}